Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL3926229 | 1.00 | ALDH1A1 (0.31) | ALDH1A1HRH3 | |
| Fluoride SCHEMBL633913 | 1.00 | — | — | |
| Fluoride SCHEMBL28235374 | 0.95 | — | — | |
| Fluoride Ion SCHEMBL963997 | 0.95 | — | — | |
| Fluoride Ion SCHEMBL131861 | 0.95 | ALDH1A1 (0.33) | ALDH1A1HRH3 | |
| Fluoride SCHEMBL1263596 | 0.95 | — | — | |
| Fluoride SCHEMBL6229645 | 0.95 | — | — | |
| SCHEMBL1334882 | 0.91 | — | — | |
| Fluoride SCHEMBL13581787 | 0.91 | ALDH1A1 (0.36) | ALDH1A1HRH3 | |
| Fluoride SCHEMBL99441 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9605261-B2 | RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end | CHEMGENES CORPORATION (US) | 2017-03-28 | — | — | US | disclosed |
| EP-2326656-B1 | RNA SYNTHESIS - PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3' - END | CHEMGENES CORP (US) | 2017-01-25 | — | — | EP | disclosed |
| US-9512162-B2 | Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides | ASED, LLC (US) | 2016-12-06 | — | — | US | disclosed |
| US-9493773-B2 | Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides | ASED, LLC (US) | 2016-11-15 | — | — | US | disclosed |
| US-9365607-B1 | Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides | ASED, LLC (US) | 2016-06-14 | — | — | US | disclosed |
| US-20150252071-A1 | Synthesis of Deuterated Ribo Nucleosides, N-Protected Phosphoramidites and Oligonucleotides | ASED, LLC | 2015-09-10 | — | — | US | disclosed |
| US-20150218557-A1 | RNA SYNTHESIS-PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3'-END | CHEMGENES CORPORATION | 2015-08-06 | — | — | US | disclosed |
| EP-2882768-A2 | SYNTHESIS OF DEUTERATED RIBO NUCLEOSIDES, N-PROTECTED PHOSPHORAMIDITES, AND OLIGONUCLEOTIDES | Ased, LLC (US) | 2015-06-17 | — | — | EP | disclosed |
| US-9045521-B2 | Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides | ASED, LLC (US) | 2015-06-02 | — | — | US | disclosed |
| US-20150119565-A1 | SYNTHESIS OF DEUTERATED RIBO NUCLEOSIDES, N-PROTECTED PHOSPHORAMIDITES, AND OLIGONUCLEOTIDES | ASED, LLC | 2015-04-30 | — | — | US | disclosed |
| US-7276337-B2 | Compositions and methods for visual ribonuclease detection assays | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| EP-1788875-A2 | NOVEL POLYNUCLEOTIDE SYNTHESIS LABELING CHEMISTRY | Dharmacon, Inc. (US) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006033730-A2 | NOVEL POLYNUCLEOTIDE SYNTHESIS LABELING CHEMISTRY | DHARMACON, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| US-6773885-B1 | INTERNUCLEOTIDE LINKAGES ARE FLANKED BY FLUORESCENT REPORTER GROUPS AND DARK QUENCHER | INTEGRATED DNA TECHNOLOGIES, INC. | 2004-08-10 | — | — | US | disclosed |
| US-20040137479-A1 | Compositions and methods for visual ribonuclease detection assays | INTEGRATED DNA TECHNOLOGIES, INC. | 2004-07-15 | — | — | US | disclosed |
| US-5750735-A | CHEMICAL INTERMEDIATES FOR ANTIBIOTICS | AMERICAN CYANAMID COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5744465-A | Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5623081-A | USING BENZYLOXYACETALDEHYDE DIMETHYL ETHER, HALOGENATED 1-PHENYLMETHOXY-4-PENTEN-2-OL; CYCLIZATION | LIN YANG-I (US) | 1997-04-22 | — | — | US | disclosed |
| US-5602118-A | A 2-((2-SUBSTITUTED ALKYL)FUR-3-YL)-THIO-),3-CARBOXY-2-CARBOPENEM DERIVATIVES; EFFECTIVE AGAINST BETA-LACTAM ANTIBIOTIC-RESISTANT BACTERIA | AMERICAN CYANAMID COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0617036-A2 | Novel 2-thiosubstituted carbapenems | AMERICAN CYANAMID COMPANY (US) | 1994-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150252071-A1 | Synthesis of Deuterated Ribo Nucleosides, N-Protected Phosphoramidites and Oligonucleotides | NSUN3, DUT, RNGTT | ALDH1A1 4252/4885HRH3 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.